Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageEBIT MarginEBITDA MarginEBT MarginEnterprise ValueFCF MarginGross MarginInventory AverageNet MarginOperating MarginReturn on AssetsReturn on Sales

Burning Rock Biotech (BNR) EBIT Margin: 2020-2024

Historic EBIT Margin for Burning Rock Biotech (BNR) over the last 5 years, with Dec 2024 value amounting to 69.32%.

  • Burning Rock Biotech's EBIT Margin rose 2174.00% to 12.22% in Q3 2025 from the same period last year, while for Sep 2025 it was 21.49%, marking a year-over-year increase of 6561.00%. This contributed to the annual value of 69.32% for FY2024, which is 5522.00% up from last year.
  • According to the latest figures from FY2024, Burning Rock Biotech's EBIT Margin is 69.32%, which was up 44.34% from 124.54% recorded in FY2023.
  • Over the past 5 years, Burning Rock Biotech's EBIT Margin peaked at 69.32% during FY2024, and registered a low of 174.07% during FY2022.
  • In the last 3 years, Burning Rock Biotech's EBIT Margin had a median value of 124.54% in 2023 and averaged 122.64%.
  • Per our database at Business Quant, Burning Rock Biotech's EBIT Margin crashed by 6,102bps in 2021 and then skyrocketed by 5,522bps in 2024.
  • Over the past 5 years, Burning Rock Biotech's EBIT Margin (MRY) stood at 95.93% in 2020, then tumbled by 64bps to 156.95% in 2021, then fell by 11bps to 174.07% in 2022, then increased by 28bps to 124.54% in 2023, then surged by 44bps to 69.32% in 2024.
  • Its EBIT Margin stands at 69.32% for FY2024, versus 124.54% for FY2023 and 174.07% for FY2022.